<DOC>
	<DOCNO>NCT00214851</DOCNO>
	<brief_summary>An open label trial Kineret ( anakinra ) induction therapy ( 100mg./day ) four week period treatment Familial Cold Urticaria . Familial Cold Urticaria ( FCU ) rare autosomal dominant condition manifesting symptom trigger exposure cold variable expression . Currently standard reliable agent available treatment patient FCU.This study evaluate efficacy Kineret ( anakinra ) , interleukin 1 receptor antagonist induction maintenance therapy patient FCU .</brief_summary>
	<brief_title>The Use Kineret ( Anakinra ) Treatment Familial Cold Urticaria</brief_title>
	<detailed_description>Product : Kineret ( anakinra ) Protocol title : The Use Kineret ( anakinra ) Treatment Familial Cold Urticaria ( FCU ) Target Disease : Familial Cold Urticaria Patients : 8 patient previously diagnose FCU live close Moncton , N.B . Study Objectives : - To assess efficacy Kineret ( anakinra ) 100mg . give subcutaneously daily subject FCU . - To demonstrate use CRP SAA objective laboratory marker effectiveness treatment . - To determine effect Kineret ( anakinra ) quality life patient FCU . Study design : An open-labelled trial Kineret ( anakinra ) induction therapy ( 100mg./day ) four week period . Treatment regimen : After initial clinical laboratory assessment , patient receive Kineret ( anakinra ) 100mg . daily four week . They observe two week without medication . Route administration : Subcutaneous injection Interval first last dose active study agent : 4 week Duration study participation : 8 week Number subject : 8 Number site : 1 Interim analysis : Daily patient diary ; weekly follow-up phone call ; CRP report</detailed_description>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Cryopyrin-Associated Periodic Syndromes</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Must 18 year age old time enrollment ; may male female Must previously diagnose Familial Cold Urticaria ( FCU ) Must react least one symptom FCU summer month least four time per week sufficiently interfere ordinary daily activity inhibit normal life enjoyment . Women must willing pregnancy test necessary , use contraceptive measure . Receiving systemic medications/treatments could affect FCU . Pregnancy , nurse planning pregnancy , , recently pregnant less three month development history serious birth defect . Have previous treatment Kineret ( anakinra ) therapeutic agent target IL1 blockade . Have use investigational drug within previous 1 month five time half life investigational agent , whichever long , 3 month biologic unknown half life . Have receive systemic medication treatment could affect symptom FCU antihistamine , corticosteroid drug , NSAIDS , anabolic medication Ketotifen within 2 week baseline visit . Have know malignancy history malignancy within previous five year ( exception basal squamous cell carcinoma skin treat evidence recurrence ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Familial Cold Urticaria</keyword>
	<keyword>Kineret ( anakinra )</keyword>
	<keyword>Interleukin 1 beta</keyword>
	<keyword>C-Reactive Protein</keyword>
	<keyword>Serum Amyloid A protein</keyword>
</DOC>